GinaAnnSuhMD

Physician

Dr. Suh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Stanford Health Care-Sponsored Stanford UniversityFellowship, Infectious Disease, 2008 - 2012
Temple University HospitalResidency, Internal Medicine, 2004 - 2007
Lewis Katz School of Medicine at Temple UniversityClass of 2004

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Triclosan, Triclocarban, and the Microbiota Start of enrollment: 2011 Jul 01
Completed
Not Applicable
Bacteriophage Therapy in Patients With Prosthetic Joint Infections Start of enrollment: 2022 Oct 01
Withdrawn
Phase 1, Phase 2
Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial Start of enrollment: 2024 Feb 22
RECRUITING
NA
Roles: Contact, Principal Investigator

PubMed

Bacteriophage therapy for multidrug-resistant infections: current technologies and therapeutic approaches.
Minyoung Kevin Kim, Gina A Suh, Grace D Cullen, Saumel Perez Rodriguez, Tejas Dharmaraj
The Journal of Clinical Investigation. 2025-03-03
Here's to a Future Beyond Reconstructive Surgery for Pelvic Osteomyelitis.
Said El Zein, Matthew M Melin, Gina A Suh, N V Tran, Peter S Rose
Clinical Infectious Diseases. 2025-02-04
Ten years of experience with elbow native joint arthritis: a multicenter retrospective cohort study.
Pansachee Damronglerd, Ryan Bijan Khodadadi, Said El Zein, Jack William McHugh, Omar M Abu Saleh
Journal of Bone and Joint Infection. 2025-01-01

91 Days Later: Biomx’s Phage Fights off Diabetic Bone Infection in Phase IIMarch 31st, 2025
Inaugural Stephen Lerner, M.D., Lecture Scheduled for Dec. 6November 18th, 2022
Do's and Don'ts of (Almost) Post-Pandemic TravelJune 15th, 2021
Join now to see all